Your browser doesn't support javascript.
loading
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).
Andrade, Adriana; Guedj, Jeremie; Rosenkranz, Susan L; Lu, Darlene; Mellors, John; Kuritzkes, Daniel R; Perelson, Alan S; Ribeiro, Ruy M.
Afiliação
  • Andrade A; aThe Johns Hopkins University, Baltimore, Maryland, USA bINSERM, IAME, UMR 1137, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France cCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts dUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania eBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts fTheoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico
AIDS ; 29(18): 2419-26, 2015 Nov 28.
Article em En | MEDLINE | ID: mdl-26558541
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / RNA Viral / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Raltegravir Potássico Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / RNA Viral / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Raltegravir Potássico Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article